Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26,866Revenue $M4,061Net Margin (%)4.8Altman Z-Score3.3
Enterprise Value $M28,140EPS $1.8Operating Margin %17.0Piotroski F-Score5
P/E(ttm)119Beneish M-Score-2.7Pre-tax Margin (%)6.1Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %21.5Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow27.9y-y EBITDA Growth Rate %11.1ROA % (ttm)1.4Higher Current Ratio y-yY
Dividend Yield %0.3PEG5.8ROE % (ttm)2.3Less Shares Outstanding y-yN
Payout Ratio %30.0Shares Outstanding M146ROIC % (ttm)5.6Gross Margin Increase y-yN

Gurus Latest Trades with PRGO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRGOMariko Gordon 2015-03-31 Sold Out -0.21%$147.77 - $173.7
($159.5)
$ 183.6815%Sold Out0
PRGORuane Cunniff 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 183.6815%Reduce 0.06%1,698,713
PRGORon Baron 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 183.6815%Reduce 3.18%76,494
PRGOJohn Keeley 2015-03-31 Add$147.77 - $173.7
($159.5)
$ 183.6815%Add 2.32%30,731
PRGOKen Fisher 2015-03-31 Reduce$147.77 - $173.7
($159.5)
$ 183.6815%Reduce 0.90%461,071
PRGOVanguard Health Care Fund 2014-12-31 Add0.21%$145.69 - $168.76
($156.26)
$ 183.6818%Add 16.64%3,855,652
PRGOJoel Greenblatt 2014-12-31 Sold Out $145.69 - $168.76
($156.54)
$ 183.6817%Sold Out0
PRGOVanguard Health Care Fund 2014-09-30 Add0.04%$139 - $158.85
($149.11)
$ 183.6823%Add 2.96%3,305,652
PRGORon Baron 2014-09-30 Add$139 - $158.85
($149.11)
$ 183.6823%Add 1.19%79,307
PRGOJoel Greenblatt 2014-09-30 Buy $139 - $158.85
($149.08)
$ 183.6823%New holding1,665
PRGOJohn Keeley 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 183.6823%Reduce 1.08%30,263
PRGORuane Cunniff 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 183.6823%Reduce 0.37%1,710,706
PRGOKen Fisher 2014-09-30 Reduce$139 - $158.85
($149.11)
$ 183.6823%Reduce 1.79%477,504
PRGOGeorge Soros 2014-06-30 Sold Out -0.13%$126.87 - $157.2
($141.62)
$ 183.6830%Sold Out0
PRGOVanguard Health Care Fund 2014-06-30 Add0.04%$126.87 - $157.2
($141.89)
$ 183.6829%Add 3.76%3,210,552
PRGOKen Fisher 2014-06-30 Add$126.87 - $157.2
($141.89)
$ 183.6829%Add 0.49%486,226
PRGOMariko Gordon 2014-06-30 Reduce$126.87 - $157.2
($141.89)
$ 183.6829%Reduce 0.09%28,494
PRGORon Baron 2014-06-30 Add$126.87 - $157.2
($141.89)
$ 183.6829%Add 0.65%78,373
PRGOJohn Keeley 2014-06-30 Add$126.87 - $157.2
($141.89)
$ 183.6829%Add 6.44%30,593
PRGORuane Cunniff 2014-06-30 Reduce$126.87 - $157.2
($141.89)
$ 183.6829%Reduce 0.11%1,717,063
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRGO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PRGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KINGMA TODD WExecutive VP, General Counsel 2015-04-29Sell1,700$190.27-3.46view
HENDRICKSON JOHN TEVP Global Operations & Supply 2015-04-14Sell8,800$200.27-8.28view
KINGMA TODD WExecutive VP, General Counsel 2015-04-13Sell1,300$198.44-7.44view
Shah JatinSr VP & Chief Scientific Offic 2015-03-13Sell2,000$165.510.98view
Yu LouisExecutive VP Global Quality 2015-03-12Sell140$166.2710.47view
Farrington ThomasSenior VP and CIO 2015-02-20Sell517$151.1821.5view
MORRIS HERMAN JRDirector 2014-11-14Sell200$154.4218.95view
Kochan SharonEVP, GM International 2014-11-10Sell5,367$156.3617.47view
Yu LouisExecutive VP Global Quality 2014-11-10Sell259$155.1118.42view
O'Connor DonalDirector 2014-11-04Sell0$018.42view

Quarterly/Annual Reports about PRGO:

News about PRGO:

Articles On GuruFocus.com
KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
Mariko Gordon Sells Lumber Liquidators, Western Digital May 19 2015 
Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
Teva Eyeing Mylan For $40 Billion Apr 23 2015 
CalAmp and Illumina Significant Earnings Growth; Perrigo Rebuffs Takeover Offer Apr 22 2015 
Weekly 52-Week Highs Highlight: BLK, HIG, PRGO, NKE Mar 23 2015 
Fournier Finds Time for His Own Investments in the Third Quarter Dec 17 2014 
David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
David Rolfe Comments on Perrigo Jan 27 2014 
Weekly Insider Sells Highlight: ROC, PRGO, JCI, TEL, DISH Dec 16 2013 

More From Other Websites
[video]Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise Jul 02 2015
History Tells Jacob Gottlieb His Top 3 Large-Cap Positions Beat The Market Jul 01 2015
Top Takeaways From BMO's Specialty Pharma Day Jul 01 2015
A New Rider in the Perrigo, Mylan, Teva Merger Merry-Go-Round Jun 30 2015
Boehringer's Roxane Labs draws bid from Hikma, Mallinckrodt- Bloomberg Jun 29 2015
Boehringer's Roxane Labs draws bid from Hikma, Mallinckrodt- Bloomberg Jun 29 2015
MEDIA-Hikma, Mallinckrodt said to bid for Boehringer's Roxane Labs - Bloomberg Jun 29 2015
EU regulators to rule on Mylan bid for Perrigo by July 29 Jun 25 2015
Mylan eyes Tel Aviv listing if Perrigo deal goes ahead Jun 24 2015
Edited Transcript of PRGO presentation 23-Jun-15 3:45pm GMT Jun 24 2015
Perrigo Going Up With Or Without Mylan, Says BMO Jun 23 2015
Mylan CFO to meet Tel Aviv bourse chief to discuss listing - source Jun 23 2015
Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog Jun 22 2015
Teva gains standing to challenge Mylan poison pill Jun 19 2015
Teva takes 4.6 percent stake in Mylan as part of bid Jun 19 2015
Teva takes 4.6 percent stake in Mylan as part of bid Jun 19 2015
Teva Takes 4.6% Stake in Mylan Jun 19 2015
Teva ups Mylan stake, handed setback in court ruling Jun 18 2015
Teva Bid for Mylan Could Be 'Imminent' Jun 18 2015
Mylan Inks Deal with Pulmatrix for Respiratory Disease Drug - Analyst Blog Jun 17 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK